Regulation and enzymatic basis of bone resorption by human osteoclasts

Clinical Science

Volumn 112, Issue 11-12, 2007, Pages 567-575

  Fuller, Karen ^a   Kirstein, Barrie ^a   Chambers, Timothy J ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Bone resorption; C terminal telopeptide degradation product of type I collagen (CTX I); Cathepsin K; Metalloproteinase (MMP); Osteoclast; Receptor activator of nuclear factor B ligand (RANKL)

Indexed keywords

ALENDRONIC ACID; BETA INTERFERON; BUCLADESINE; CALCITONIN; CARBOXY TERMINAL TELOPEPTIDE; CATHEPSIN K INHIBITOR; CYCLOSPORIN A; DIBUTYRYL CYCLIC GMP; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1; MACROPHAGE INFLAMMATORY PROTEIN 1 GAMMA; MATRIX METALLOPROTEINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; N [N (3 CARBOXYOXIRANE 2 CARBONYL)LEUCYL]AGMATINE; OSTEOCLAST DIFFERENTIATION FACTOR; PARATHYROID HORMONE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REGULATION; FEMALE; HUMAN; HUMAN CELL; MALE; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL;

ADULT; BONE DENSITY CONSERVATION AGENTS; BONE RESORPTION; CALCITONIN; CATHEPSINS; CELLS, CULTURED; COLLAGEN TYPE I; CYTOKINES; ENZYME INHIBITORS; FEMALE; HOMEOSTASIS; HUMANS; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGED; OSTEOCLASTS; PEPTIDES; RANK LIGAND;

EID: 34249791173     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20060274     Document Type: Article

References (40)

1. Chambers, T. J. (2000) Regulation of the differentiation and function of osteoclasts. J. Pathol. 192, 4-13
2. Suda, T., Takahashi, N., Udagawa, N., Jimi, E., Gillespie, M. T. and Martin, T. J. (1999) Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr. Rev. 20, 345-357
3. Takayanagi, H. (2005) Mechanistic insight into osteoclast differentiation in osteoimmunology. J. Mol. Med. 83, 170-179
4. Matsuzaki, K., Udagawa, N., Takahashi, N. et al. (1998) Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures. Biochem. Biophys. Res. Commun. 246, 199-204
5. Sabokbar, A. and Athanasou, N. S. (2003) Generating human osteoclasts from peripheral blood. Methods Mol. Med. 80, 101-111
6. Akatsu, T., Tamura, T., Takahashi, N. T. et al. (1992) Preparation and characterization of a mouse osteoclast-like multinucleated cell population. J. Bone Miner. Res. 7, 1297-1306
7. Wesolowski, G., Duong, L. T., Lakkakorpi, P. T. et al. (1995) Isolation and characterization of highly enriched, prefusion mouse osteoclastic cells. Exp. Cell Res. 219, 679-686
8. Susa, M., Luong-Nguyen, N. H., Cappellen, D., Zamurovic, N. and Gamse, R. (2004) Human primary osteoclasts: in vitro generation and applications as pharmacological and clinical assay. J. Transl. Med. 2, 6
9. Foged, N. T., Delaisse, J. M., Hou, P. et al. (1996) Quantification of the collagenolytic activity of isolated osteoclasts by enzyme-linked immunosorbent assay. J. Bone Miner. Res. 11, 226-237
10. Husheem, M., Nyman, J. K., Vaaraniemi, J., Vaananen, H. K. and Hentunen, T. A. (2005) Characterization of circulating human osteoclast progenitors: development of in vitro resorption assay. Calcif. Tissue Int. 76, 222-230
11. Kirstein, B., Grabowska, U., Samuelsson, B., Shiroo, M., Chambers, T. J. and Fuller, K. (2006) A novel assay for analysis of the regulation of the function of human osteoclasts. J. Transl. Med. 7, 45
12. Chambers, T. J., McSheehy, P. M., Thomson, B. M. and Fuller, K. (1985) The effect of calcium-regulating hormones and prostaglandins on bone resorption by osteoclasts disaggregated from neonatal rabbit bones. Endocrinology 116, 234-239
13. Fuller, K., Wong, B., Fox, S., Choi, Y. and Chambers, T. J. (1998) TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts. J. Exp. Med. 188, 997-1001
14. Burgess, T. L., Qian, Y., Kaufman, S. et al. (1999) The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts. J. Cell Biol. 145, 527-538
15. Nishi, Y., Atley, L., Eyre, D. E. et al. (1999) Determination of bone markers in pycnodysostosis: effects of cathepsin K. deficiency on bone matrix degradation. J. Bone Miner. Res. 14, 1902-1908
16. Henriksen, K., Sorensen, M. G., Nielsen, R. H. et al. (2006) Degradation of the organic phase of bone by osteoclasts: a secondary role for lysosomal acidification. J Bone Miner. Res. 21, 58-66
17. Sassi, M. L., Aman, S., Hakala, M., Luukkainen, R. and Risteli, J. (2003) Assay for cross-linked carboxyterminal telopeptide of type I collagen (ICTP) unlike CrossLaps assay reflects increased pathological degradation of type I collagen in rheumatoid arthritis. Clin. Chem. Lab. Med. 41, 1038-1044
18. Garnero, P., Ferreras, M., Karsdal, M. A. et al. (2003) The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation. J. Bone Miner. Res. 18, 859-867
19. Miller, S. C. (1978) Rapid activation of the medullary bone osteoclast cell surface by parathyroid hormone. J. Cell Biol. 76, 615-618
20. Chambers, T. J. (1985) The pathobiology of the osteoclast. J. Clin. Pathol. 38, 241-252
21. Teitelbaum, S. L. (2000) Bone resorption by osteoclasts. Science 289, 1504-1508
22. Azuma, Y., Kaji, K., Katogi, R., Takeshita, S. and Kudo, A. (2000) Tumor necrosis factor-α induces differentiation of and bone resorption by osteoclasts. J. Biol. Chem. 275, 4858-4864
23. Fuller, K., Murphy, C., Kirstein, B., Fox, S. W. and Chambers, T. J. (2002) TNFα potently activates osteoclasts, through a direct action independent of and strongly synergistic with RANKL. Endocrinology 143, 1108-1118
24. Jimi, E., Nakamura, I., Duong, L. T. et al. (1999) Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells. Exp. Cell Res. 247, 84-93
25. Kudo, O., Fujikawa, Y., Itonaga, I., Sabokbar, A., Torisu, T. and Athanasou, N. A. (2002) Proinflammatory cytokine (TNFα/IL-1α) induction of human osteoclast formation. J. Pathol. 198, 220-227
26. Kobayashi, K., Takahashi, N., Jimi, E. et al. (2000) Tumor necrosis factor α stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J. Exp. Med. 191, 275-286
27. Fox, S. W., Fuller, K., Bayley, K. E., Lean, J. M. and Chambers, T. J. (2000) TGF-β1 and IFN-γ direct macrophage activation by TNF-α to osteoclastic or cytocidal phenotype. J. Immunol. 165, 4957-4963
28. Takayanagi, H., Kim, S., Matsuo, K. et al. (2002) RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-β. Nature 416, 744-749
29. Takayanagi, H., Kim, S., Koga, T. et al. (2002) Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell 3, 889-901
30. Matsuo, K., Galson, D. L., Zhao, C. et al. (2004) Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos. J. Biol. Chem. 279, 26475-26480
31. Zaidi, M., Datta, H. K., Patchell, A., Moonga, B. and MacIntyre, I. (1989) 'Calcium-activated' intracellular calcium elevation: a novel mechanism of osteoclast regulation. Biochem. Biophys. Res. Commun. 163, 1461-1465
32. Malgaroli, A., Meldolesi, J., Zallone, A. Z. and Teti, A. (1989) Control of cytosolic free calcium in rat and chicken osteoclasts. The role of extracellular calcium and calcitonin. J. Biol. Chem. 264, 14342-14347
33. Zaidi, M., Kerby, J., Huang, C. L. et al. (1991) Divalent cations mimic the inhibitory effect of extracellular ionised calcium on bone resorption by isolated rat osteoclasts: further evidence for a 'calcium receptor'. J. Cell. Physiol. 149, 422-427
34. Yip, K. H., Zheng, M. H., Steer, J. H. et al. (2005) Thapsigargin modulates osteoclastogenesis through the regulation of RANKL-induced signaling pathways and reactive oxygen species production. J. Bone Miner. Res. 20, 1462-1471
35. Kiviranta, R., Morko, J., Alatalo, S. L. et al. (2005) Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio. Bone 36, 159-172
36. Sassi, M. L., Eriksen, H., Risteli, L. et al. (2000) Immunochemical characterization of assay for carboxyterminal telopeptide of human type I collagen: loss of antigenicity by treatment with cathepsin K. Bone 26, 367-373
37. Delaisse, J. M., Engsig, M. T., Everts, V. et al. (2000) Proteinases in bone resorption: obvious and less obvious roles. Clin. Chim. Acta 291, 223-234
38. Engsig, M. T., Chen, Q. J. and Vu, T. H. (2000) Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones. J. Cell Biol. 151, 879-889
39. Fuller, K. and Chambers, T. J. (1995) Localisation of mRNA for collagenase in osteocytic, bone surface and chondrocytic cells but not osteoclasts. J. Cell Sci. 108, 2221-2230
40. Everts, V., Delaisse, J. M., Korper, W. et al. (2002) The bone lining cell: its role in cleaning Howship's lacunae and initiating bone formation. J. Bone Miner. Res. 17, 77-90